{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:44:13Z","timestamp":1762505053904},"reference-count":9,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2005,10,10]]},"DOI":"10.1200\/jco.2005.02.6138","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T21:33:15Z","timestamp":1128634395000},"page":"7361-7362","source":"Crossref","is-referenced-by-count":18,"title":["Persistent Residual Disease in t(11;18)(q21;q21) Positive Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Chemotherapy or Rituximab"],"prefix":"10.1200","volume":"23","author":[{"given":"Antonio","family":"Salar","sequence":"first","affiliation":[{"name":"Departments of Clinical Hematology and Pathology, Hospital del Mar, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Bellosillo","sequence":"additional","affiliation":[{"name":"Departments of Clinical Hematology and Pathology, Hospital del Mar, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Serrano","sequence":"additional","affiliation":[{"name":"Departments of Clinical Hematology and Pathology, Hospital del Mar, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Besses","sequence":"additional","affiliation":[{"name":"Departments of Clinical Hematology and Pathology, Hospital del Mar, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"BIB1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.128"},{"key":"BIB2","doi-asserted-by":"crossref","unstructured":"Liu H, Ruskone-Fourmestraux A, Lavergne-Slove A, et al: Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 6:39,2001-40,","DOI":"10.1016\/S0140-6736(00)03571-6"},{"key":"BIB3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09711-8"},{"key":"BIB4","doi-asserted-by":"publisher","DOI":"10.1159\/000079502"},{"key":"BIB5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403202"},{"key":"BIB6","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65012-2"},{"key":"BIB7","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"BIB8","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64630-5"},{"key":"BIB9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.08.674"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2005.02.6138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:12:19Z","timestamp":1653513139000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2005.02.6138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,10]]},"references-count":9,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2005,10,10]]}},"alternative-id":["10.1200\/JCO.2005.02.6138"],"URL":"https:\/\/doi.org\/10.1200\/jco.2005.02.6138","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,10]]}}}